Elsevier

The Lancet Neurology

Volume 18, Issue 7, July 2019, Pages 697-708
The Lancet Neurology

Review
Gait impairments in Parkinson's disease

https://doi.org/10.1016/S1474-4422(19)30044-4Get rights and content

Summary

Gait impairments are among the most common and disabling symptoms of Parkinson's disease. Nonetheless, gait is not routinely assessed quantitatively but is described in general terms that are not sensitive to changes ensuing with disease progression. Quantifying multiple gait features (eg, speed, variability, and asymmetry) under natural and more challenging conditions (eg, dual-tasking, turning, and daily living) enhanced sensitivity of gait quantification. Studies of neural connectivity and structural network topology have provided information on the mechanisms of gait impairment. Advances in the understanding of the multifactorial origins of gait changes in patients with Parkinson's disease promoted the development of new intervention strategies, such as neurostimulation and virtual reality, aimed at alleviating gait impairments and enhancing functional mobility. For clinical applicability, it is important to establish clear links between specific gait impairments, their underlying mechanisms, and disease progression to foster the acceptance and usability of quantitative gait measures as outcomes in future disease-modifying clinical trials.

Introduction

The typical pathological manifestations of Parkinson's disease (bradykinesia, rigidity, and reduced amplitude and automaticity of movement) affect the gait patterns of patients with the disease. Patients have reduced gait speed and step length, increased axial rigidity, and impaired rhythmicity. Gait problems worsen as the disease progresses, which is a major disease burden that markedly affects independence and quality of life (panel).1, 8 Although dopaminergic medications improve certain aspects of walking such as velocity and step length, temporal characteristics and episodic symptoms such as freezing of gait, defined as the sudden inability to continue walking despite the intent to maintain locomotion, have responses that are much more variable.2, 20 Gold-standard dopaminergic treatments also create multiple challenges that can further impair gait, including fluctuations in motor response (so-called wearing off) and dyskinesia.4 Thus, optimal evaluation and treatment of alterations in gait in patients with Parkinson's disease demands an understanding of the multiple mechanisms and factors that contribute to these problems.

The current understanding of gait impairments in patients with Parkinson's disease is based mainly on cross-sectional studies that do not provide insights into individual gait changes associated with disease progression.3, 7, 8 The rare use of quantitative assessment of gait (eg, speed and variability) in the routine clinical examination and poor understanding of the underlying mechanisms limits the use of gait measures as viable outcomes for assessing disease progression and effects of treatment. Advances in wearable technology and imaging techniques have generated knowledge relevant to assessment, understanding of mechanisms, and treatment of gait impairments in patients with Parkinson's disease. Low-cost sensing technology (eg, accelerometers and gyroscopes) is rapidly replacing complex camera-based motion-capture systems, allowing clinicians to quantitatively assess gait not only in the clinic but also during daily living activities in the home and community settings. This method of measurement provides valuable information on habitual function, motor fluctuations, and response to medications. Neuroimaging techniques that record neural activity during walking have advanced the understanding of the mechanisms causing aberrant gait patterns in patients with Parkinson's disease, leading to the design of more effective clinical interventions.21, 22, 23, 24, 25, 26

This Review evaluates the advances made in three related aspects of gait impairments in patients with Parkinson's disease: assessment, mechanisms, and interventions to improve gait. The Review highlights the gaps in knowledge and provides insights that might lead to new discoveries and innovations to improve clinical decisions and treatments.

Section snippets

Gait assessment in clinical and research settings

The approach to assessing gait evolved from just a few items on the Unified Parkinson's Disease Rating Scale (UPDRS),27 the most commonly used rating scale for symptoms of Parkinson's disease, to more detailed observational and quantitative assessments of different aspects of gait associated with functional limitations (table 1). Many observational scales (eg, Dynamic Gait Index)28 and performance-based tests (eg, Timed Up and Go Test)28 have been validated and used in the clinic, providing

Differences in gait phenotypes

Symptomatic heterogeneity in patients with Parkinson's disease has led to the classification of the disease into subtypes, such as PIGD and tremor-dominant. This classification is based on items from the UPDRS.58 Compared with patients with the tremor-dominant subtype, those with the PIGD subtype are typically less responsive to levodopa and are more likely to develop motor fluctuations and dyskinesia, non-motor symptoms, and dementia.53, 59, 60 Patients with the PIGD subtype have slower gait

Interventions

The most common treatment for motor dysfunction in patients with Parkinson's disease is dopaminergic. However, there is increasing evidence, particularly from the past 5 years, on the efficacy of non-pharmacological interventions to improve motor function and gait and to reduce the risk of falling.

Conclusions and future directions

Walking is fundamental to everyday functioning and independence, and Parkinson's disease markedly affects this ability. A better understanding of the reasons and ways in which the motor and non-motor features of Parkinson's disease impact on gait can inform and enhance clinical care and provide a roadmap for future research. Therefore, in this Review, we summarised recent advances on assessment, mechanisms, and treatments of gait impairments in Parkinson's disease. Evidence suggests that

Search strategy and selection criteria

We searched PubMed for articles published in English between Jan 1, 2013, and Dec 31, 2018, using the search terms “gait” (OR “ambulation” OR “locomotion” OR “walking”) and “Parkinson's disease”. We selected research articles whose primary focus was related to gait and that had results relevant to assessment, mechanisms, or interventions that address impairments of gait in patients with Parkinson's disease.

References (101)

  • I Maidan et al.

    Altered brain activation in complex walking conditions in patients with Parkinson's disease

    Parkinsonism Relat Disord

    (2016)
  • L Rennie et al.

    The reliability of gait variability measures for individuals with Parkinson's disease and healthy older adults—the effect of gait speed

    Gait Posture

    (2018)
  • R Morris et al.

    A model of free-living gait: a factor analysis in Parkinson's disease

    Gait Posture

    (2017)
  • M Capecci et al.

    A smartphone-based architecture to detect and quantify freezing of gait in Parkinson's disease

    Gait Posture

    (2016)
  • J Camps et al.

    Deep learning for freezing of gait detection in Parkinson's disease patients in their homes using a waist-worn inertial measurement unit

    Knowl Based Sys

    (2018)
  • M Gilat et al.

    Dysfunctional limbic circuitry underlying freezing of gait in Parkinson's disease

    Neuroscience

    (2018)
  • D Orcioli-Silva et al.

    Objective measures of unobstructed walking and obstacle avoidance in Parkinson's disease subtypes

    Gait Posture

    (2018)
  • T Konno et al.

    Comparison of clinical features among Parkinson's disease subtypes: a large retrospective study in a single center

    J Neurol Sci

    (2018)
  • T Simuni et al.

    How stable are Parkinson's disease subtypes in de novo patients: analysis of the PPMI cohort?

    Parkinsonism Relat Disord

    (2016)
  • M Mancini et al.

    The clinical significance of freezing while turning in Parkinson's disease

    Neuroscience

    (2017)
  • J Li et al.

    Decreased interhemispheric homotopic connectivity in Parkinson's disease patients with freezing of gait: a resting state fMRI study

    Parkinsonism Relat Disord

    (2018)
  • DS Peterson et al.

    Brain activity during complex imagined gait tasks in Parkinson disease

    Clin Neurophysiol

    (2014)
  • JM Shine et al.

    Abnormal patterns of theta frequency oscillations during the temporal evolution of freezing of gait in Parkinson's disease

    Clin Neurophysiol

    (2014)
  • JB Toledo et al.

    High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease

    Neurobiol Dis

    (2014)
  • C Tard et al.

    Attention modulation during motor preparation in Parkinsonian freezers: a time-frequency EEG study

    Clin Neurophysiol

    (2016)
  • FC Chang et al.

    24 h Levodopa-carbidopa intestinal gel may reduce falls and “unresponsive” freezing of gait in Parkinson's disease

    Parkinsonism Relat Disord

    (2015)
  • J Jankovic et al.

    Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial

    Parkinsonism Relat Disord

    (2014)
  • A Delval et al.

    Gait and attentional performance in freezers under methylphenidate

    Gait Posture

    (2015)
  • C Geroin et al.

    Does dual-task training improve spatiotemporal gait parameters in Parkinson's disease?

    Parkinsonism Relat Disord

    (2018)
  • JW Wang et al.

    Deep brain stimulation of pedunculopontine nucleus for postural instability and gait disorder after Parkinson disease: a meta-analysis of individual patient data

    World Neurosurg

    (2017)
  • G Albani et al.

    “Masters and servants” in parkinsonian gait: a three-dimensional analysis of biomechanical changes sensitive to disease progression

    Funct Neurol

    (2014)
  • B Galna et al.

    Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype

    Mov Disord

    (2015)
  • M Pistacchi et al.

    Gait analysis and clinical correlations in early Parkinson's disease

    Funct Neurol

    (2017)
  • NW Sterling et al.

    Dopaminergic modulation of arm swing during gait among Parkinson's disease patients

    J Parkinsons Dis

    (2015)
  • A Mirelman et al.

    Arm swing as a potential new prodromal marker of Parkinson's disease

    Mov Disord

    (2016)
  • M Djuric-Jovicic et al.

    Selection of gait parameters for differential diagnostics of patients with de novo Parkinson's disease

    Neurol Res

    (2017)
  • S Mellone et al.

    The quality of turning in Parkinson's disease: a compensatory strategy to prevent postural instability?

    J Neuroeng Rehabil

    (2016)
  • M Son et al.

    Evaluation of the turning characteristics according to the severity of Parkinson disease during the timed up and go test

    Aging Clin Exp Res

    (2017)
  • L Palmerini et al.

    Identification of characteristic motor patterns preceding freezing of gait in Parkinson's disease using wearable sensors

    Front Neurol

    (2017)
  • EN Beck et al.

    Freezing of gait in Parkinson's disease: an overload problem?

    PLoS One

    (2015)
  • RG Cohen et al.

    Inhibition, executive function, and freezing of gait

    J Parkinsons Dis

    (2014)
  • S Rezvanian et al.

    Motor subtypes of Parkinson's disease can be identified by frequency component of postural stability

    Sensors (Basel)

    (2018)
  • E Yusupov et al.

    Medication use and falls: applying Beers criteria to medication review in Parkinson's disease

    SAGE Open Med

    (2017)
  • C Curtze et al.

    Levodopa is a double-edged sword for balance and gait in people with Parkinson's disease

    Mov Disord

    (2015)
  • C Barthel et al.

    The laser shoes: a new ambulatory device to alleviate freezing of gait in Parkinson disease

    Neurology

    (2018)
  • M Mancini et al.

    Assessment of the ability of open- and closed-loop cueing to improve turning and freezing in people with Parkinson's disease

    Sci Rep

    (2018)
  • M Schenkman et al.

    Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial

    JAMA Neurol

    (2018)
  • T Warlop et al.

    Does Nordic walking restore the temporal organization of gait variability in Parkinson's disease?

    J Neuroeng Rehabil

    (2017)
  • CG Goetz et al.

    Movement disorder society-sponsored revision of the unified parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results

    Mov Disord

    (2008)
  • BR Bloem et al.

    Measurement instruments to assess posture, gait, and balance in Parkinson's disease: critique and recommendations

    Mov Disord

    (2016)
  • Cited by (346)

    View all citing articles on Scopus
    View full text